| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.41) by 24...